🔎 Trials Near Me

Akèy › Kolit Ulseratif › North Carolina › Durham

Etid klinik pou Kolit Ulseratif nan Durham, NC

10 etid pou Kolit Ulseratif ap chèche patisipan nan sit nan ak bò kote Durham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 2
  • University of North Carolina, Chapel Hill · 10 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 30, 2026 · NCT06598943

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Ap rekriteFaz 2
  • Site 041, Durham
  • 040, Chapel Hill · 10 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07012395

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 3
  • University of North Carolina, Chapel Hill · 10 mi lwen
Laj 12 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07196748

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Ap rekriteFaz 4
  • University of North Carolina, Chapel Hill · 10 mi lwen
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT06095128

A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically

Ap rekriteFaz 4
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Fanm · Mizajou Aug 28, 2026 · NCT07654751

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 3
  • Duke University Medical Center - Site Number: 8400093, Durham
  • UNC Hospitals, The University of North Carolina at Chapel Hill - Site Number: 8400074, Chapel Hill · 10 mi lwen
Laj 16 a 80 · Tout sèks · Mizajou Aug 20, 2026 · NCT07184996

BOOM-IBD2 Pivotal Clinical Trial

Ap rekrite
  • UNC Chapel Hill, Chapel Hill · 10 mi lwen
Laj 18 a 85 · Tout sèks · Mizajou Aug 6, 2026 · NCT06571669

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

Ap rekriteEtid obsèvasyon
  • University of North Carolina, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07237516

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

Ap rekriteEtid obsèvasyon
  • University of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology, Chapel Hill · 10 mi lwen
Laj 18 a 64 · Tout sèks · Mizajou Jul 9, 2026 · NCT06398626

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

Ap rekriteEtid obsèvasyon
  • University of North Carolina, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 8, 2025 · NCT06750731

Etid Kolit Ulseratif nan lòt vil

Lòt etid nan Durham

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.